Entry Point Capital, LLC Procept Bio Robotics Corp Transaction History
Entry Point Capital, LLC
- $171 Million
- Q3 2024
A detailed history of Entry Point Capital, LLC transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Entry Point Capital, LLC holds 5,850 shares of PRCT stock, worth $572,013. This represents 0.27% of its overall portfolio holdings.
Number of Shares
5,850Holding current value
$572,013% of portfolio
0.27%Shares
3 transactions
Others Institutions Holding PRCT
# of Institutions
267Shares Held
38MCall Options Held
262KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA4.84MShares$474 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$341 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.53MShares$150 Million0.04% of portfolio
-
Loomis Sayles & CO L P1.24MShares$122 Million0.13% of portfolio
-
State Street Corp Boston, MA1.18MShares$115 Million0.0% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $4.36B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...